In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts. If you want to see more such stocks on the list, go directly to Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets.
05. Costco Wholesale Corporation (NASDAQ:COST)
Upside Potential: 13%
On December 29, Tigress Financial increased its price target for Costco Wholesale Corporation (NASDAQ:COST), a prominent player in the retail industry, from $635.00 to $745.00 while maintaining a Buy rating on the shares. This adjustment implies an impressive upside potential of 13%. Tigress Financial’s decision to raise the price target reflects their positive outlook on Costco Wholesale Corporation (NASDAQ:COST) future performance. The increased target signifies Tigress Financial’s confidence in the company’s ability to deliver sustained growth and capitalize on market trends within the retail sector. Investors should take note of the substantial upside potential of 13% indicated by the revised price target. Tigress Financial’s Buy rating underscores their belief that Costco Wholesale Corporation (NASDAQ:COST) is well-positioned to navigate the competitive retail landscape and generate significant value for shareholders. Tigress Financial’s analysis provides investors with a comprehensive perspective on the potential opportunities associated with investing in Costco Wholesale Corporation (NASDAQ:COST). As the retail industry evolves, Costco Wholesale appears poised for growth, according to Tigress Financial, making this research note a valuable resource for investors considering positions in the retail sector.
04. Carnival Corporation & plc (NYSE:CCL)
Upside Potential: 19%
On December 29, Macquarie adjusted its price target for Carnival Corporation & plc (NYSE:CCL), a major player in the cruise industry, from $16.00 to $22.00 while maintaining an Outperform rating on the shares. This modification indicates a notable upside potential of 19%. Macquarie’s decision to increase the price target reflects their positive assessment of Carnival Corporation & plc (NYSE:CCL) future prospects. The revised target underscores Macquarie’s confidence in Carnival’s ability to rebound within the cruise industry and capitalize on the recovery in travel and leisure activities.
Investors should take note of the substantial upside potential of 19% as indicated by the adjusted price target. Macquarie’s Outperform rating signals their belief that Carnival is well-positioned to navigate the challenges faced by the cruise industry and regain momentum. Macquarie’s analysis provides investors with insights into the opportunities associated with investing in Carnival Corporation & plc (NYSE:CCL), emphasizing the potential for growth within the cruise industry. As travel and tourism recover, Carnival Corporation & plc may present an attractive investment opportunity, according to Macquarie’s outlook, making this research note valuable for investors considering positions in the travel and leisure sector.
03. Natera, Inc. (NASDAQ:NTRA)
Upside Potential: 36%
On December 29, BTIG Research revised its price target for Natera, Inc. (NASDAQ:NTRA), a notable player in the genetic testing and diagnostics industry, from $75.00 to $85.00 while maintaining a Buy rating on the shares. This adjustment suggests a substantial upside potential of 36%. BTIG Research’s decision to increase the price target reflects their optimistic outlook for Natera’s future performance. The revised target underscores BTIG Research’s confidence in Natera, Inc. (NASDAQ:NTRA) position within the genetic testing and diagnostics sector, emphasizing potential growth opportunities and market trends. Investors should take note of the significant upside potential of 36% as indicated by the adjusted price target. BTIG Research’s Buy rating signals their belief that Natera is well-positioned to capitalize on advancements in genetic testing technologies and gain a competitive edge in the industry. As the genetic testing and diagnostics field continues to evolve, Natera, Inc. (NASDAQ:NTRA) may present a compelling investment prospect, according to BTIG Research’s outlook, making this research note a valuable resource for investors considering positions in the healthcare and diagnostics sector.
Alger Spectra Fund made the following comment about Natera, Inc. (NASDAQ:NTRA) in its Q2 2023 investor letter:
“Natera, Inc. (NASDAQ:NTRA) is a specialty lab providing genetic testing services in the reproductive health, oncology and transplant markets. Reproductive health tests are run to screen for common genetic disorders such as trisomy 13, 18, and 21 in pregnant women – these tests are also known as non-invasive prenatal testing (NIPT). The company’s oncology franchise is led by Signatera, a test used to detect minimal residual disease (MRD) – the applications of this test are primarily to monitor therapy response and detect cancer recurrence. Lastly, Natera’s transplant franchise is led by Prospera, a test used to monitor transplant organ rejection. Natera’s tests are all based on the company’s proprietary liquid biopsy platform to detect cell-free DNA. Shares detracted from performance this quarter after the company reported lower than expected fiscal first quarter gross margins. Moreover, we believe investors sold shares this quarter following a strong first quarter rally after the Centers for Medicare & Medicaid Services (CMS) announced they would cover Natera’s Signatera Breast tests. Despite this quarter’s decline in share price, the company reported solid quarterly revenues that beat analyst estimates, driven by strong volumes in women’s health and management raised its fiscal 2023 revenue guidance above consensus.”
02. Tripadvisor, Inc. (NASDAQ:TRIP)
Upside Potential: 39%
On December 29, Ascendiant Capital Markets adjusted its price target for Tripadvisor, Inc. (NASDAQ:TRIP), a significant player in the online travel and restaurant reservation industry, from $27.00 to $30.00 while maintaining a Buy rating on the shares. This modification suggests a substantial upside potential of 39%. Ascendiant Capital Markets’ decision to increase the price target reflects their optimistic outlook for Tripadvisor’s future performance. The revised target underscores Ascendiant Capital Markets’ confidence in Tripadvisor, Inc. (NASDAQ:TRIP) position within the online travel and restaurant reservation sector, emphasizing potential growth avenues and emerging trends.
Investors should take note of the significant upside potential of 39% as indicated by the adjusted price target. Ascendiant Capital Markets’ Buy rating signals their belief that Tripadvisor, Inc. (NASDAQ:TRIP) is well-positioned to navigate the evolving landscape of online travel and restaurant reservations, capitalizing on increased consumer activity in the post-pandemic era. Ascendiant Capital Markets’ analysis provides investors with valuable insights into the potential opportunities associated with investing in Tripadvisor, Inc. (NASDAQ:TRIP). As the travel and dining industries recover, Tripadvisor, Inc. (NASDAQ:TRIP) may present an attractive investment opportunity, according to Ascendiant Capital Markets’ outlook, making this research note a valuable resource for investors considering positions in the online travel and restaurant reservation sector.
Rowan Street Capital made the following comment about Tripadvisor, Inc. (NASDAQ:TRIP) in its second quarter 2023 investor letter:
“Now, the bottom 3 performers from all the companies that we’d sold were Docusign (DOCU) -76%, Tripadvisor, Inc. (NASDAQ:TRIP) -59% and Under Armour (UA) -57%. These represent the losses we would have incurred had we held on to these positions until now. We must note that all 3 of these were sold for purely fundamental reasons and we ended up being correct on all of them.”
01. Hudson Pacific Properties, Inc. (NYSE:HPP)
Upside Potential: 40%
On December 29, BTIG Research revised its price target for Hudson Pacific Properties, Inc. (NYSE:HPP), a significant player in the real estate and property management industry, from $11.00 to $13.00 while maintaining a Buy rating on the shares. This adjustment suggests a substantial upside potential of 40%. BTIG Research’s decision to increase the price target reflects their positive outlook for Hudson Pacific Properties’ future performance. The revised target underscores BTIG Research’s confidence in Hudson Pacific Properties, Inc. (NYSE:HPP) position within the real estate and property management sector, emphasizing potential growth avenues and market trends. Investors should take note of the significant upside potential of 40% as indicated by the adjusted price target. BTIG Research’s Buy rating signals their belief that Hudson Pacific Properties is well-positioned to capitalize on evolving trends in the real estate market and property management industry. As the real estate market continues to adapt to changing dynamics, Hudson Pacific Properties, Inc. (NYSE:HPP) may present an attractive investment opportunity, according to BTIG Research’s outlook, making this research note a valuable resource for investors considering positions in the real estate and property management sector.
You can also take a peek at Top 20 Most Unfriendly States in the US and 13 Most Profitable Renewable Energy Stocks.
